Episode Details

In this week's episode we’ll discuss the mutational and transcriptional landscape of pediatric BCP lymphoblastic leukemia; learn more about the role of platelet-derived TGF-β1 in immune thrombocytopenia; and discuss the findings from a phase 3 trial of mavorixafor in WHIM syndrome.

Featured Articles:

• Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma 
• Platelet-derived TGF-β1 induces functional reprogramming of myeloid-derived suppressor cells in immune thrombocytopenia 
• Phase 3 randomized trial of mavorixafor, CXCR4 antagonist, in WHIM syndrome